Researchers at Western University and Lawson Health Research Institute are using tobacco plants as ‘green bioreactors’ to produce an anti-inflammatory protein with powerful therapeutic potential.
The plants are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing potential for treating a number of inflammatory and autoimmune disorders like type 2 diabetes, stroke, dementia and arthritis.
“This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases,” said Dr. Tony Jevnikar, Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson. “The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury.”
And while showing promise in animal models, IL-37’s use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.
That’s where the tobacco plants come in.
This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. “The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods,” said Shengwu Ma, PhD, Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. “Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks.”
The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they’ve shown they can produce the protein in tobacco, it can be translated to other plants, like potatoes.
Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.
“I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable,” Dr. Jevnikar said.
The Latest on: Green bioreactors
via Google News
The Latest on: Green bioreactors
- Algae’s energy potential bloomson May 11, 2022 at 5:00 pm
The project is unmistakably green, a shade that can be produced ... only a few in the world to include functioning, pilot-scale bioreactors connected to a municipal wastewater treatment plant.
- If You Care About Humanity, Chill Out on the Steakson May 10, 2022 at 5:04 am
A one-fifth drop in beef consumption would cut deforestation in half, analysis finds.
- Canadian lab seeks volunteers in Argentina to test new covid vaccineon May 9, 2022 at 5:00 pm
Argentina's National Administration of Drugs, Food and Medical Technology (Anmat) Tuesday gave the green light for the ... on the use of live plants as bioreactors to reproduce a non-infectious ...
- Should we draw a new line between development and conserving our countryside?on May 6, 2022 at 10:03 pm
Cover crops, changes to drainage regimes and the use of so-called bioreactors might help farming ... their hands in their pockets? East Anglia Green, the proposed pylon line stretching from ...
- ‘We invented the cow 10,000 years ago. Lab-grown meat’s the next step’on May 5, 2022 at 6:01 pm
Every year, 70 billion animals are slaughtered at an enormous cost to the planet. How close are we to a high-tech alternative?
- Bioreactors Market Will Reach USD 2154.4 Million By 2028 With A CAGR of 6.0% - Valuates Reportson May 5, 2022 at 1:40 pm
BANGALORE, India, May 5, 2022 /PRNewswire/ -- Bioreactors market is Segmented by Type - Disposable, Reusable, by Application - Research and Development, Biopharmaceutical, Others. Global ...
- Why the steepest slopes often yield the best wineson May 5, 2022 at 3:54 am
Another cost is running the bioreactors – either enormous ones ... “We would be waiting for 18 months with limited feedback and fingers crossed for the green light. Without guidance, it is likely they ...
- Swapping 20% of beef for microbial protein ‘could halve deforestation’on May 4, 2022 at 9:37 am
The bioreactors used to create microbial protein require heating, and using high-carbon sources of electricity would offset part of their benefit, but green electricity is expanding quickly as ...
- Single-Use Bioreactors Market Expected to Rise Steadily throughout 2017-2026on May 2, 2022 at 11:50 pm
Single-use bioreactors, which are ideally suited for manufacturing biopharmaceutical products because of their high-performance, have become highly evolved these days thanks to constant efforts by ...
- Energy crisis lifeline: ‘Green diesel’ produced from microalgae could replace fossil fuelson May 2, 2022 at 6:15 am
The team reported: “A lower heating value approximately equal to fossil low-sulphur diesel and high ignition quality qualify microalgae-derived ‘green’ diesel for diesel engines utilisation.” ...
via Bing News